Cluster Management Excellence reconfirmed for the BioRN Network e.V..
BioRN Network e.V. has been recently awarded with the “Cluster Management Excellence Label SILVER – Proven for Cluster Excellence”.
In 2008, the cluster successfully participated in the Leading-Edge Cluster Competition (“Spitzencluster-Wettbewerb”) of the German Federal Ministry of Education and Research (BMBF). In 2013, BioRN was awarded the “Cluster Management Excellence Label GOLD” followed by a successful participation in a BMBF funding programme for the internationalisation of Leading-Edge Clusters in 2015.
In line with efforts to scale-up the cluster’s internationalisation activities, the establishment of a new Executive Board and a newly implemented strategic Board in 2017, BioRN wanted to demonstrate both to their cluster and potential partners that we are still on the path towards cluster management excellence. The Silver Label of the European Cluster Excellence Initiative is a quality label in its own right and confirms the successful implementation of improvement processes that were initiated following a Bronze label benchmarking.
BioRN is a member of the “go-cluster” programme, and the peer review process took place within the framework of the programme and in cooperation with the European Secretariat for Cluster Analysis (ESCA).
ESCA (www.cluster-analysis.org) has been mandated by the European Cluster Excellence Initiative to organise the assessment process and to award successful cluster organisations with the Silver Label of the European Cluster Excellence Initiative.
The “Cluster Management Excellence Label SILVER” is valid until November 2020, when by then BioRN will be audit again for the gold label.
BioRN – Life Science Cluster Rhine-Neckar
BioRN is a life science research and industry cluster dedicated to the development of cell-specific, molecular and personalised innovative treatments. The BioRN Cluster stands for the development, networking, representation and promotion of the life science region into one of the leading life science clusters in Europe. The cluster-members include renowned academic research institutions such as the Universities of Heidelberg, the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL) and global health care companies such as AbbVie, Boehringer Ingelheim, Johnson & Johnson, Merck, Roche, und Sanofi-Aventis, and about 80 small and medium-sized biotech enterprises. Beyond the members registered in the cluster, BioRN gives access to a wider network via partnerships and collaborations. In terms of the use of clusters for the internationalization of companies, BioRN has founded, together with Leuven (Belgium), Maastricht (Netherlands) and Copenhagen (Denmark), an alliance for the enforcement of biomedical innovation in Europe, called the Health Axis Europe.